•  
  •  
  •  
  •  

2025-08-08 21:34:36

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  WALCHANDPEOPLEFIRST

Stock Report

  • Walchand Peoplefirst Limited recommends final dividend of Rs. 1
  • Walchand Peoplefirst Ltd Q4 FY25 PAT at Rs. 35.49 lakhs
  • Walchand Peoplefirst Ltd Q1 FY25 loss at Rs. 21.74 lakhs
  • Walchand Peoplefirst Ltd Q4 FY2024 profit slips QoQ to Rs. 98.59 lakhs
  • Walchand Peoplefirst Ltd Q3 FY2023-24 net profit up QoQ at Rs. 1.15 crore
  • Walchand Peoplefirst Ltd Q2 FY2024 PAT jumps to Rs. 95.65 lakhs
  • Walchand Peoplefirst Ltd Q1 FY2023-24 net profit rises to Rs. 31.58 lakhs
  • Walchand Peoplefirst Ltd recommends dividend of Rs. 1
  • Walchand Peoplefirst Ltd Q4 FY23 PAT slides QoQ to Rs. 11.28 lakhs
  • Walchand Peoplefirst Ltd Q3FY23 PAT jumps to Rs. 2.79 crore
  • Walchand Peoplefirst Ltd Q2 FY2022-23 PAT at Rs. 48.38 lakhs
  • Walchand Peoplefirst Ltd reports profit of Rs. 10.72 lakhs in Q1 FY2023
  • Walchand Peoplefirst Ltd recommends dividend of Rs. 1.25
  • Walchand Peoplefirst Q4FY22 loss at Rs. 80.07 lakhs
  • Walchand Peoplefirst Q3FY22 net profit jumps to Rs. 1.73 crore
  • Walchand Peoplefirst Ltd posts PAT of Rs. 1.37 crore in Q2FY22

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024